Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

04.06.2018

1 Am J Nurs
1 Anticancer Res
1 Biomed Pharmacother
2 BJU Int
2 BMC Cancer
1 Cancer Causes Control
1 Cancer Manag Res
1 Cancer Med
1 Cell Stress Chaperones
1 Clin Epigenetics
1 Int Braz J Urol
1 Int J Clin Oncol
1 J Biophotonics
1 J Immunol Res
2 JAMA
1 Klin Onkol
1 Onco Targets Ther
3 Oncol Lett
1 Oncology
1 Oncotarget
1 Sci Rep
1 Transpl Infect Dis
1 Turk J Urol
1 Virchows Arch
1 World J Urol



    Am J Nurs

  1. ASCHENBRENNER DS
    Bladder Cancer Drug Approved to Treat Stage III Non-Small Cell Lung Cancer.
    Am J Nurs. 2018;118:26-27.
    >> Share


    Anticancer Res

  2. MOURMOURAS N, Philippou A, Christopoulos P, Kostoglou K, et al
    Differential Expression of IGF-I Transcripts in Bladder Cancer.
    Anticancer Res. 2018;38:3453-3459.
    >> Share


    Biomed Pharmacother

  3. ZHOU L, Wei E, Zhou B, Bi G, et al
    Anti-proliferative benefit of curcumol on human bladder cancer cells via inactivating EZH2 effector.
    Biomed Pharmacother. 2018;104:798-805.
    >> Share


    BJU Int

  4. EREDICS K, Bretterbauer KM, Comploj E, Friedl A, et al
    Bladder cancer in nonagenarians:a multicenter study of 123 patients.
    BJU Int. 2018 May 27. doi: 10.1111/bju.14419.
    >> Share

  5. MARI A, Kimura S, Foerster B, Abufaraj M, et al
    A Systematic Review and Meta-Analysis of the impact of Lymphovascular Invasion in Bladder Cancer Transurethral Resection Specimens.
    BJU Int. 2018 May 28. doi: 10.1111/bju.14417.
    >> Share


    BMC Cancer

  6. XIE H, Zhu Y, Zhang J, Liu Z, et al
    B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.
    BMC Cancer. 2018;18:590.
    >> Share

  7. KWON WA, Joung JY, Lim J, Oh CM, et al
    Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.
    BMC Cancer. 2018;18:617.
    >> Share


    Cancer Causes Control

  8. VAN OSCH FHM, Jochems SHJ, Reulen RC, Pirrie SJ, et al
    The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.
    Cancer Causes Control. 2018 May 30. pii: 10.1007/s10552-018-1046.
    >> Share


    Cancer Manag Res

  9. SHANG Z, Wang J, Wang X, Yan H, et al
    Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients.
    Cancer Manag Res. 2018;10:1177-1190.
    >> Share


    Cancer Med

  10. DUDEK AM, van Kampen JGM, Witjes JA, Kiemeney LALM, et al
    LINC00857 expression predicts and mediates the response to platinum-based chemotherapy in muscle-invasive bladder cancer.
    Cancer Med. 2018 Jun 1. doi: 10.1002/cam4.1570.
    >> Share


    Cell Stress Chaperones

  11. ANDOLINO C, Hess C, Prince T, Williams H, et al
    Drug-induced keratin 9 interaction with Hsp70 in bladder cancer cells.
    Cell Stress Chaperones. 2018 May 25. pii: 10.1007/s12192-018-0913.
    >> Share


    Clin Epigenetics

  12. VAN DER HEIJDEN AG, Mengual L, Ingelmo-Torres M, Lozano JJ, et al
    Urine cell-based DNA methylation classifier for monitoring bladder cancer.
    Clin Epigenetics. 2018;10:71.
    >> Share


    Int Braz J Urol

  13. ROBINSON SP, Farooq A, Laniado M, Motiwala H, et al
    The demographic features, clinical outcomes, prognosis and treatment options for patients with sarcomatoid carcinoma of the urinary bladder: a single centre experience.
    Int Braz J Urol. 2018;44:45-52.
    >> Share


    Int J Clin Oncol

  14. WAKAI K, Utsumi T, Yoneda K, Oka R, et al
    Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumor.
    Int J Clin Oncol. 2018 May 26. pii: 10.1007/s10147-018-1299.
    >> Share


    J Biophotonics

  15. CHEN H, Li X, Broderick N, Liu Y, et al
    Identification and characterization of bladder cancer by low-resolution fiber-optic Raman spectroscopy.
    J Biophotonics. 2018 May 24:e201800016. doi: 10.1002/jbio.201800016.
    >> Share


    J Immunol Res

  16. JIN Z, Yao J, Xie N, Cai L, et al
    Melittin Constrains the Expression of Identified Key Genes Associated with Bladder Cancer.
    J Immunol Res. 2018;2018:5038172.
    >> Share


    JAMA

  17. MESSING EM, Tangen CM, Lerner SP, Sahasrabudhe DM, et al
    Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
    JAMA. 2018;319:1880-1888.
    >> Share

  18. KAFFENBERGER SD, Miller DC, Nielsen ME
    Simplifying Treatment and Reducing Recurrence for Patients With Early-Stage Bladder Cancer.
    JAMA. 2018;319:1864-1865.
    >> Share


    Klin Onkol

  19. JURACEK J, Stanik M, Peltanova B, Adamcova S, et al
    [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
    Klin Onkol. 2018;31.
    >> Share


    Onco Targets Ther

  20. WANG Y, Liu J, Yang X, Liu Y, et al
    Bacillus Calmette-Guerin and anti-PD-L1 combination therapy boosts immune response against bladder cancer.
    Onco Targets Ther. 2018;11:2891-2899.
    >> Share


    Oncol Lett

  21. RAHMAT JN, Esuvaranathan K, Mahendran R
    Bacillus Calmette-Guerin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival.
    Oncol Lett. 2018;15:9231-9241.
    >> Share

  22. XU Y, Tong Y, Ying J, Lei Z, et al
    Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells.
    Oncol Lett. 2018;15:9117-9125.
    >> Share

  23. WANG JP, Leng JY, Zhang RK, Zhang L, et al
    Functional analysis of gene expression profiling-based prediction in bladder cancer.
    Oncol Lett. 2018;15:8417-8423.
    >> Share


    Oncology

  24. HA HK, Koo PJ, Kim SJ
    Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis.
    Oncology. 2018;95:31-38.
    >> Share


    Oncotarget

  25. SHINDO T, Niinuma T, Nishiyama N, Shinkai N, et al
    Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer.
    Oncotarget. 2018;9:24457-24469.
    >> Share


    Sci Rep

  26. EBBING J, Heckmann RC, Collins JW, Miller K, et al
    Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer.
    Sci Rep. 2018;8:8360.
    >> Share


    Transpl Infect Dis

  27. ZIEGLER J, Ho J, Gibson IW, Nayak JG, et al
    Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer.
    Transpl Infect Dis. 2018 May 29:e12931. doi: 10.1111/tid.12931.
    >> Share


    Turk J Urol

  28. BOLAT D, Celik S, Aydin ME, Aydogdu O, et al
    Assessment of the quality of life and sexual functions of patients followed-up for non-muscle invasive bladder cancer: preliminary results of the prospective-descriptive study.
    Turk J Urol. 2018 Mar 9:1-6. doi: 10.5152/tud.2018.30040.
    >> Share


    Virchows Arch

  29. BARTH I, Schneider U, Grimm T, Karl A, et al
    Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.
    Virchows Arch. 2018;472:749-758.
    >> Share


    World J Urol

  30. ROUANNE M, Roumiguie M, Houede N, Masson-Lecomte A, et al
    Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways.
    World J Urol. 2018 Jun 1. pii: 10.1007/s00345-018-2332.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016